H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 670 KRW 1.24% Market Closed
Market Cap: 584.1B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Hyundai Bioscience Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyundai Bioscience Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Cash from Investing Activities
-â‚©9.6B
CAGR 3-Years
38%
CAGR 5-Years
9%
CAGR 10-Years
-18%
AmorePacific Corp
KRX:090430
Cash from Investing Activities
-â‚©363.1B
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amorepacific Group
KRX:002790
Cash from Investing Activities
-â‚©414.9B
CAGR 3-Years
16%
CAGR 5-Years
-10%
CAGR 10-Years
2%
Cosmax Inc
KRX:192820
Cash from Investing Activities
-â‚©110.1B
CAGR 3-Years
-24%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Cash from Investing Activities
-â‚©562B
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
-9%
Kolmar Korea Co Ltd
KRX:161890
Cash from Investing Activities
-â‚©148.6B
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
-25%
No Stocks Found

Hyundai Bioscience Co Ltd
Glance View

Market Cap
584.1B KRW
Industry
Consumer products

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H

See Also

What is Hyundai Bioscience Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-9.6B KRW

Based on the financial report for Jun 30, 2024, Hyundai Bioscience Co Ltd's Cash from Investing Activities amounts to -9.6B KRW.

What is Hyundai Bioscience Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-18%

The average annual Cash from Investing Activities growth rates for Hyundai Bioscience Co Ltd have been 38% over the past three years , 9% over the past five years , and -18% over the past ten years .

Back to Top